58 research outputs found
Alzheimers Disease Diagnosis using Machine Learning: A Review
Alzheimers Disease AD is an acute neuro disease that degenerates the brain
cells and thus leads to memory loss progressively. It is a fatal brain disease
that mostly affects the elderly. It steers the decline of cognitive and
biological functions of the brain and shrinks the brain successively, which in
turn is known as Atrophy. For an accurate diagnosis of Alzheimers disease,
cutting edge methods like machine learning are essential. Recently, machine
learning has gained a lot of attention and popularity in the medical industry.
As the illness progresses, those with Alzheimers have a far more difficult time
doing even the most basic tasks, and in the worst case, their brain completely
stops functioning. A persons likelihood of having early-stage Alzheimers
disease may be determined using the ML method. In this analysis, papers on
Alzheimers disease diagnosis based on deep learning techniques and
reinforcement learning between 2008 and 2023 found in google scholar were
studied. Sixty relevant papers obtained after the search was considered for
this study. These papers were analysed based on the biomarkers of AD and the
machine-learning techniques used. The analysis shows that deep learning methods
have an immense ability to extract features and classify AD with good accuracy.
The DRL methods have not been used much in the field of image processing. The
comparison results of deep learning and reinforcement learning illustrate that
the scope of Deep Reinforcement Learning DRL in dementia detection needs to be
explored.Comment: 10 pages and 3 figure
Towards Practical Application of Deep Learning in Diagnosis of Alzheimer's Disease
Accurate diagnosis of Alzheimer's disease (AD) is both challenging and time
consuming. With a systematic approach for early detection and diagnosis of AD,
steps can be taken towards the treatment and prevention of the disease. This
study explores the practical application of deep learning models for diagnosis
of AD. Due to computational complexity, large training times and limited
availability of labelled dataset, a 3D full brain CNN (convolutional neural
network) is not commonly used, and researchers often prefer 2D CNN variants. In
this study, full brain 3D version of well-known 2D CNNs were designed, trained
and tested for diagnosis of various stages of AD. Deep learning approach shows
good performance in differentiating various stages of AD for more than 1500
full brain volumes. Along with classification, the deep learning model is
capable of extracting features which are key in differentiating the various
categories. The extracted features align with meaningful anatomical landmarks,
that are currently considered important in identification of AD by experts. An
ensemble of all the algorithm was also tested and the performance of the
ensemble algorithm was superior to any individual algorithm, further improving
diagnosis ability. The 3D versions of the trained CNNs and their ensemble have
the potential to be incorporated in software packages that can be used by
physicians/radiologists to assist them in better diagnosis of AD.Comment: 18 pages, 8 figure
Machine Learning for Multiclass Classification and Prediction of Alzheimer\u27s Disease
Alzheimer\u27s disease (AD) is an irreversible neurodegenerative disorder and a common form of dementia. This research aims to develop machine learning algorithms that diagnose and predict the progression of AD from multimodal heterogonous biomarkers with a focus placed on the early diagnosis. To meet this goal, several machine learning-based methods with their unique characteristics for feature extraction and automated classification, prediction, and visualization have been developed to discern subtle progression trends and predict the trajectory of disease progression.
The methodology envisioned aims to enhance both the multiclass classification accuracy and prediction outcomes by effectively modeling the interplay between the multimodal biomarkers, handle the missing data challenge, and adequately extract all the relevant features that will be fed into the machine learning framework, all in order to understand the subtle changes that happen in the different stages of the disease. This research will also investigate the notion of multitasking to discover how the two processes of multiclass classification and prediction relate to one another in terms of the features they share and whether they could learn from one another for optimizing multiclass classification and prediction accuracy.
This research work also delves into predicting cognitive scores of specific tests over time, using multimodal longitudinal data. The intent is to augment our prospects for analyzing the interplay between the different multimodal features used in the input space to the predicted cognitive scores. Moreover, the power of modality fusion, kernelization, and tensorization have also been investigated to efficiently extract important features hidden in the lower-dimensional feature space without being distracted by those deemed as irrelevant.
With the adage that a picture is worth a thousand words, this dissertation introduces a unique color-coded visualization system with a fully integrated machine learning model for the enhanced diagnosis and prognosis of Alzheimer\u27s disease. The incentive here is to show that through visualization, the challenges imposed by both the variability and interrelatedness of the multimodal features could be overcome. Ultimately, this form of visualization via machine learning informs on the challenges faced with multiclass classification and adds insight into the decision-making process for a diagnosis and prognosis
Alzheimers Disease Diagnosis by Deep Learning Using MRI-Based Approaches
The most frequent kind of dementia of the nervous system, Alzheimer's
disease, weakens several brain processes (such as memory) and eventually
results in death. The clinical study uses magnetic resonance imaging to
diagnose AD. Deep learning algorithms are capable of pattern recognition and
feature extraction from the inputted raw data. As early diagnosis and stage
detection are the most crucial elements in enhancing patient care and treatment
outcomes, deep learning algorithms for MRI images have recently allowed for
diagnosing a medical condition at the beginning stage and identifying
particular symptoms of Alzheimer's disease. As a result, we aimed to analyze
five specific studies focused on AD diagnosis using MRI-based deep learning
algorithms between 2021 and 2023 in this study. To completely illustrate the
differences between these techniques and comprehend how deep learning
algorithms function, we attempted to explore selected approaches in depth
Novel Deep Learning Models for Medical Imaging Analysis
abstract: Deep learning is a sub-field of machine learning in which models are developed to imitate the workings of the human brain in processing data and creating patterns for decision making. This dissertation is focused on developing deep learning models for medical imaging analysis of different modalities for different tasks including detection, segmentation and classification. Imaging modalities including digital mammography (DM), magnetic resonance imaging (MRI), positron emission tomography (PET) and computed tomography (CT) are studied in the dissertation for various medical applications. The first phase of the research is to develop a novel shallow-deep convolutional neural network (SD-CNN) model for improved breast cancer diagnosis. This model takes one type of medical image as input and synthesizes different modalities for additional feature sources; both original image and synthetic image are used for feature generation. This proposed architecture is validated in the application of breast cancer diagnosis and proved to be outperforming the competing models. Motivated by the success from the first phase, the second phase focuses on improving medical imaging synthesis performance with advanced deep learning architecture. A new architecture named deep residual inception encoder-decoder network (RIED-Net) is proposed. RIED-Net has the advantages of preserving pixel-level information and cross-modality feature transferring. The applicability of RIED-Net is validated in breast cancer diagnosis and Alzheimer’s disease (AD) staging. Recognizing medical imaging research often has multiples inter-related tasks, namely, detection, segmentation and classification, my third phase of the research is to develop a multi-task deep learning model. Specifically, a feature transfer enabled multi-task deep learning model (FT-MTL-Net) is proposed to transfer high-resolution features from segmentation task to low-resolution feature-based classification task. The application of FT-MTL-Net on breast cancer detection, segmentation and classification using DM images is studied. As a continuing effort on exploring the transfer learning in deep models for medical application, the last phase is to develop a deep learning model for both feature transfer and knowledge from pre-training age prediction task to new domain of Mild cognitive impairment (MCI) to AD conversion prediction task. It is validated in the application of predicting MCI patients’ conversion to AD with 3D MRI images.Dissertation/ThesisDoctoral Dissertation Industrial Engineering 201
Prediction of Alzheimer Disease using LeNet-CNN model with Optimal Adaptive Bilateral Filtering
Alzheimer's disease is a kind of degenerative dementia that causes progressively worsening memory loss and other cognitive and physical impairments over time. Mini-Mental State Examinations and other screening tools are helpful for early detection, but diagnostic MRI brain analysis is required. When Alzheimer's disease (AD) is detected in its earliest stages, patients may begin protective treatments before permanent brain damage has occurred. The characteristics of the lesion sites in AD affected role, as identified by MRI, exhibit great variety and are dispersed across the image space, as demonstrated in cross-sectional imaging investigations of the disease. Optimized Adaptive Bilateral filtering using a deep learning model was suggested as part of this study's approach toward this end. Denoising the pictures with the help of the suggested adaptive bilateral filter is the first stage (ABF). The ABF improves denoising in edge, detail, and homogenous areas separately. After then, the ABF is given a weight, and the Adaptive Equilibrium Optimizer is used to determine the best possible value for that weight (AEO). LeNet, a CNN model, is then used to complete the AD organization. The first step in using the LeNet-5 network model to identify AD is to study the model's structure and parameters. The ADNI experimental dataset was used to verify the suggested technique and compare it to other models. The experimental findings prove that the suggested method can achieve a classification accuracy of 97.43%, 98.09% specificity, 97.12% sensitivity, and 89.67% Kappa index. When compared against competing algorithms, the suggested model emerges victorious
Artificial Intelligence on FDG PET Images Identifies Mild Cognitive Impairment Patients with Neurodegenerative Disease
[EN] The purpose of this project is to develop and validate a Deep Learning (DL) FDG PET imaging algorithm able to identify patients with any neurodegenerative diseases (Alzheimer's Disease (AD), Frontotemporal Degeneration (FTD) or Dementia with Lewy Bodies (DLB)) among patients with Mild Cognitive Impairment (MCI). A 3D Convolutional neural network was trained using images from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. The ADNI dataset used for the model training and testing consisted of 822 subjects (472 AD and 350 MCI). The validation was performed on an independent dataset from La Fe University and Polytechnic Hospital. This dataset contained 90 subjects with MCI, 71 of them developed a neurodegenerative disease (64 AD, 4 FTD and 3 DLB) while 19 did not associate any neurodegenerative disease. The model had 79% accuracy, 88% sensitivity and 71% specificity in the identification of patients with neurodegenerative diseases tested on the 10% ADNI dataset, achieving an area under the receiver operating characteristic curve (AUC) of 0.90. On the external validation, the model preserved 80% balanced accuracy, 75% sensitivity, 84% specificity and 0.86 AUC. This binary classifier model based on FDG PET images allows the early prediction of neurodegenerative diseases in MCI patients in standard clinical settings with an overall 80% classification balanced accuracy.This work was financially supported by INBIO 2019 (DEEPBRAIN), INNVA1/2020/83(DEEPPET) funded by Generalitat Valenciana, and PID2019-107790RB-C22 funded by MCIN/AEI/10.13039/501100011033/. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org).The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.Prats-Climent, J.; Gandia-Ferrero, MT.; Torres-Espallardo, I.; Álvarez-Sanchez, L.; Martinez-Sanchis, B.; Cháfer-Pericás, C.; Gómez-Rico, I.... (2022). Artificial Intelligence on FDG PET Images Identifies Mild Cognitive
Impairment Patients with Neurodegenerative Disease. Journal of Medical Systems. 46(8):1-13. https://doi.org/10.1007/s10916-022-01836-w11346
Automated medical diagnosis of alzheimer´s disease using an Efficient Net convolutional neural network
Producción CientíficaAlzheimer's disease (AD) poses an enormous challenge to modern healthcare. Since 2017, researchers have been using deep learning (DL) models for the early detection of AD using neuroimaging biomarkers. In this paper, we implement the EfficietNet-b0 convolutional neural network (CNN) with a novel approach—"fusion of end-to-end and transfer learning"—to classify different stages of AD. 245 T1W MRI scans of cognitively normal (CN) subjects, 229 scans of AD subjects, and 229 scans of subjects with stable mild cognitive impairment (sMCI) were employed. Each scan was preprocessed using a standard pipeline. The proposed models were trained and evaluated using preprocessed scans. For the sMCI vs. AD classification task we obtained 95.29% accuracy and 95.35% area under the curve (AUC) for model training and 93.10% accuracy and 93.00% AUC for model testing. For the multiclass AD vs. CN vs. sMCI classification task we obtained 85.66% accuracy and 86% AUC for model training and 87.38% accuracy and 88.00% AUC for model testing. Based on our experimental results, we conclude that CNN-based DL models can be used to analyze complicated MRI scan features in clinical settings.Publicación en abierto financiada por el Consorcio de Bibliotecas Universitarias de Castilla y León (BUCLE), con cargo al Programa Operativo 2014ES16RFOP009 FEDER 2014-2020 DE CASTILLA Y LEÓN, Actuación:20007-CL - Apoyo Consorcio BUCL
Applications of Deep Learning Techniques for Automated Multiple Sclerosis Detection Using Magnetic Resonance Imaging: A Review
Multiple Sclerosis (MS) is a type of brain disease which causes visual, sensory, and motor problems for people with a detrimental effect on the functioning of the nervous system. In order to diagnose MS, multiple screening methods have been proposed so far; among them, magnetic resonance imaging (MRI) has received considerable attention among physicians. MRI modalities provide physicians with fundamental information about the structure and function of the brain, which is crucial for the rapid diagnosis of MS lesions. Diagnosing MS using MRI is time-consuming, tedious, and prone to manual errors. Research on the implementation of computer aided diagnosis system (CADS) based on artificial intelligence (AI) to diagnose MS involves conventional machine learning and deep learning (DL) methods. In conventional machine learning, feature extraction, feature selection, and classification steps are carried out by using trial and error; on the contrary, these steps in DL are based on deep layers whose values are automatically learn. In this paper, a complete review of automated MS diagnosis methods performed using DL techniques with MRI neuroimaging modalities is provided. Initially, the steps involved in various CADS proposed using MRI modalities and DL techniques for MS diagnosis are investigated. The important preprocessing techniques employed in various works are analyzed. Most of the published papers on MS diagnosis using MRI modalities and DL are presented. The most significant challenges facing and future direction of automated diagnosis of MS using MRI modalities and DL techniques are also provided
- …